Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.
Areej A MalhaniMushira A EnaniFatemeh Saheb Sharif-AskariMona R AlghareebRoaa T Bin-BrikanSafar A AlShahraniRabih HalwaniImad M TleyjehPublished in: PloS one (2021)
Early IFN-based triple therapy was associated with lower 28-days mortality as compared to FPV.